Axsome Therapeutics, Inc. (AXSM) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Axsome Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -49.60x | -14.11x | -15.11x | -16.76x | -10.90x | -29.46x |
| P/B Ratio | 102.90x | 71.10x | 18.93x | 28.62x | 90.93x | 26.64x |
| P/S Ratio | 14.23x | 10.51x | 13.36x | 62.67x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 92.6% | 91.4% | 90.4% | 89.6% | 0.0% | 0.0% |
| Operating Margin | -26.5% | -72.7% | -85.7% | -359.3% | 0.0% | 0.0% |
| Net Margin | -28.7% | -74.5% | -88.4% | -374.0% | 0.0% | 0.0% |
| EBITDA Margin | -26.3% | -70.7% | -83.1% | -350.5% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 1.55x | 2.11x | 3.63x | 2.54x | 3.75x | 7.85x |
| Quick Ratio | 1.48x | 2.04x | 3.52x | 2.50x | 3.75x | 7.85x |
| Leverage | ||||||
| Debt/Equity | 2.73x | 3.38x | 0.98x | 0.86x | 3.18x | 0.44x |
YoY = year-over-year change. Source: FMP..